Lecture 11 – The Biochemistry of Plasmalogen Supplementation: Breaking Alzheimer’s – The Definitive Lecture Series
When it became clear that several serious, mortal, and mostly untreatable rare diseases were due to defects in peroxisomes and that plasmalogen deficiency alone is sufficient to cause mortality and morbidity in these diseases, research into the biochemical pathways necessary for the biosynthesis of plasmalogens was intensified. The peroxisomal biosynthesis of plasmalogens was (and still is) believed to end at the formation of the alkyl ether bond and …